Better use of existing drugs increases cervical cancer survival, study suggests
Treatment with existing drugs before standard treatment for cervical cancer may lead to a 35% reduction in the risk of death or the return of cancer, a study has suggested.
Researchers assessed whether a short course of induction chemotherapy (IC) – using a drug to destroy as many cancer cells as possible – before chemoradiation (CRT) could reduce rates of relapse and death.
